1 - 4 GBq/ml solution injectable

DRUG2 trials

Sponsors

Leids Universitair Medisch Centrum (LUMC), Stichting Amsterdam UMC

Conditions

Fibrous dysplasia/McCune-Albright syndromePsoriasis

Phase 2

[18F]Fluoride PET-CT in psoriasis patients at risk for developing psoriatic arthritis

RecruitingCTIS2024-514759-13-01

Stichting Amsterdam UMCPsoriasis

Start: 2024-12-16Target: 15Updated: 2024-12-16

Phase 3

DEnosumab for the treatment of FIbrous Dysplasia/McCune-Albright Syndrome in adults (DeFiD): a randomized double-blind placebo-controlled trial

RecruitingCTIS2024-511090-30-00

Leids Universitair Medisch Centrum (LUMC)Fibrous dysplasia/McCune-Albright syndrome

Start: 2023-06-13Target: 82Updated: 2025-01-27